-
公开(公告)号:US20210284617A1
公开(公告)日:2021-09-16
申请号:US16327079
申请日:2017-08-03
申请人: Amgen Inc.
发明人: Matthew BEAVER , Sheng CUI , Xiangqing SHI
IPC分类号: C07D301/12 , B01J31/16
摘要: The present invention provides new methods for preparing compound 5, and pharmaceutically acceptable salts thereof, of structure Compound 5, or a pharmaceutically acceptable salt thereof, is an important intermediate in the synthesis of carfilzomib. The invention further provides methods of making a useful manganese catalyst that may be used in the epoxidation step of the present invention.